The Pediatric Cardiomyopathy Registry and Heart Failure: Key Results from the First 15 Years

Heart Failure Clinics

Volumn 6, Issue 4, 2010, Pages 401-413

  Wilkinson, James D ^a   Landy, David C ^a   Colan, Steven D ^b   Towbin, Jeffrey A ^c   Sleeper, Lynn A ^d   Orav, E John ^e   Cox, Gerald F ^b   Canter, Charles E ^f   Hsu, Daphne T ^g,i   Webber, Steven A ^h   Lipshultz, Steven E ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^d NEW ENGLAND RESEARCH INSTITUTES   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

^f ST LOUIS CHILDREN S HOSPITAL   (United States)

^g CHILDREN S HOSPITAL AT MONTEFIORE   (United States)

^h CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

ⁱ ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Cardiomyopathy; Heart failure; Pediatric cardiomyopathy registry; Pediatrics

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

BECKER MUSCULAR DYSTROPHY; CARDIOMYOPATHY; CHILD; CHILD HEALTH QUESTIONNAIRE; CONGESTIVE CARDIOMYOPATHY; DUCHENNE MUSCULAR DYSTROPHY; ECHOCARDIOGRAPHY; FUNCTIONAL STATUS; GENE MUTATION; HEART FAILURE; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; INBORN ERROR OF METABOLISM; INCIDENCE; MALFORMATION SYNDROME; MORTALITY; MYOCARDITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PEDIATRIC CARDIOLOGY; PREVALENCE; QUESTIONNAIRE; REGISTER; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT OUTCOME;

CARDIOMYOPATHY, DILATED; CARDIOMYOPATHY, HYPERTROPHIC; CARDIOTONIC AGENTS; CHILD; CONGRESSES AS TOPIC; GROWTH DISORDERS; HEART FAILURE; HEART TRANSPLANTATION; HUMANS; INCIDENCE; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE (U.S.); PREVALENCE; REGISTRIES; RISK FACTORS; UNITED STATES;

EID: 77956893147     PISSN: 15517136     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hfc.2010.05.002     Document Type: Review

References (65)

1. Towbin J.A., Lowe A.M., Colan S.D., et al. Incidence, causes, and outcomes of dilated cardiomyopathy in children. JAMA 2006, 296:1867-1876.
2. Webber S.A. New-onset heart failure in children in the absence of structural congenital heart disease. Circulation 2008, 117:11-12.
3. Andrews R.E., Fenton M.J., Ridout D.A., et al. New-onset heart failure due to heart muscle disease in childhood: a prospective study in the United Kingdom and Ireland. Circulation 2008, 117:79-84.
4. Massin M.M., Astadicko I., Dessy H. Epidemiology of heart failure in a tertiary pediatric center. Clin Cardiol 2008, 31:388-391.
5. Grenier M.A., Osganian S.K., Cox G.F., et al. Design and implementation of the North American Pediatric Cardiomyopathy Registry. Am Heart J 2000, 139:S86-S95.
6. Bione S., D'Adamo P., Maestrini E., et al. A novel X-linked gene, G4.5, is responsible for Barth syndrome. Nat Genet 1996, 12:385-389.
7. Schlame M., Towbin J.A., Heerdt P.M., et al. Deficiency of tetralinoleoyl-cardiolipin in Barth syndrome. Ann Neurol 2002, 51:634-637.
8. Lipshultz S.E., Sleeper L.A., Towbin J.A., et al. The incidence of pediatric cardiomyopathy in two regions of the United States. N Engl J Med 2003, 348:1647-1655.
9. Arola A., Jokinen E., Ruuskanen O., et al. Epidemiology of idiopathic cardiomyopathies in children and adolescents. A nationwide study in Finland. Am J Epidemiol 1997, 146:385-393.
10. Nugent A.W., Daubeney P.E.F., Chondros P., et al. The epidemiology of childhood cardiomyopathy in Australia. N Engl J Med 2003, 348:1639-1646.
11. Colan S.D., Lipshultz S.E., Lowe A.M., et al. Epidemiology and cause specific outcome of hypertrophic cardiomyopathy in children: findings from the Pediatric Cardiomyopathy Registry. Circulation 2007, 115:773-781.
12. Cox G.F., Sleeper L.A., Lowe A.M., et al. Factors associated with establishing a causal diagnosis for children with cardiomyopathy. Pediatrics 2006, 118:1519-1531.
13. Harmon W.G., Sleeper L.A., Cuniberti L., et al. Treating children with idiopathic dilated cardiomyopathy (from the Pediatric Cardiomyopathy Registry). Am J Cardiol 2009, 104:281-286.
14. Rosenthal D., Chrisant M.R., Edens E., et al. International Society for Heart and Lung Transplantation: practice guidelines for the management of heart failure in children. J Heart Lung Transplant 2004, 23:1313-1333.
15. Miller TL, Orav EJ, Wilkinson JD, et al. Nutritional status associated with cardiac outcomes and mortality in children with idiopathic dilated cardiomyopathy. Oral presentation at the 2009 American Heart Association Scientific Sessions [abstract]. Orlando (FL), November 18, 2009.
16. Connuck D.M., Sleeper L.A., Colan S.D., et al. Characteristics and outcomes of cardiomyopathy in children with Duchenne or Becker muscular dystrophy: a comparative study from the Pediatric Cardiomyopathy Registry. Am Heart J 2008, 155:998-1005.
17. Cox GF, Colan SD, Towbin JA, et al. Mitochondrial disorders: characteristics and outcomes from the pediatric cardiomyopathy registry [abstract]. In: Proceedings of the 5th World Congress of Paediatric Cardiology and Cardiac Surgery 2009;5:134.
18. Lipshultz S.E., Orav E.J., Wilkinson J.D., et al. A risk stratification analysis of predictors of death or transplant in children with hypertrophic cardiomyopathy. Circulation 2008, 118(Suppl):4956.
19. Wilkinson J.D., Lowe A.M., Salbert B.A., et al. Outcomes in children with Noonan syndrome and cardiomyopathy [abstract]. Circulation 2007, 116(Suppl II):513.
20. Jefferies JL, Colan SD, Sleeper LA, et al. Outcome and risk stratification for children with left ventricular noncompaction: findings from the pediatric cardiomyopathy registry [abstract]. Oral presentation at the 2009 American Heart Association Scientific Sessions. Orlando (FL), November 16, 2009.
21. Webber S., Lipshultz S.E., Sleeper L.A., et al. Phenotypic heterogeneity and outcomes of restrictive cardiomyopathy in childhood: a report from the NHLBI pediatric cardiomyopathy registry [abstract]. Circulation 2008, 118(Suppl):6071.
22. Singh T.P., Gauvreau K., Thiagarajan R., et al. Racial and ethnic differences in mortality in children awaiting heart transplant in the United States. Am J Transplant 2009, 9:1-8.
23. Pietra B.A., Kantor P.F., Bartlett H.L., et al. Clinical factors associated with UNOS status and outcome after listing for heart transplant in children with dilated cardiomyopathy [abstract]. Circulation 2007, 116(Suppl II):565.
24. Larsen R., Naftel D.C., Rosenthal D.N., et al. The impact of heart failure severity at time of listing for cardiac transplantation on short and long term stability with pediatric cardiomyopathy [abstract]. Circulation 2008, 118(Suppl):4953.
25. Kelley R.I., Cheatham J.P., Clark B.J., et al. X-linked dilated cardiomyopathy with neutropenia, growth retardation, and 3-methylglutaconic aciduria. J Pediatr 1991, 119:738-747.
26. Sleeper LA, Towbin JA, Colan SD, et al. Functional status is impaired and correlated with clinical status in pediatric cardiomyopathy [abstract]. In: Proceedings of the 5th World Congress of Paediatric Cardiology and Cardiac Surgery 2009;5:134.
27. Towbin J.A., Sleeper L., Jefferies J.L., et al. Genetic and viral genome analysis of childhood cardiomyopathy: the PCMR/PCSR experience [abstract]. J Am Coll Cardiol 2010, 55. A43.E409.
28. Lipshultz S.E., Colan S.D., Towbin J.A., et al. Introduction for " idiopathic and primary cardiomyopathy in children" Prog Pediatr Cardiol 2007, 23(1-2):3.
29. Colan S.D. Classification of the cardiomyopathies. Prog Pediatr Cardiol 2007, 23(1-2):5-15.
30. Weintraub R.G., Nugent A.W., Daubeney P.E.F. Pediatric cardiomyopathy: the Australian experience. Prog Pediatr Cardiol 2007, 23(1-2):17-24.
31. Alvarez J.A., Wilkinson J.D., Lipshultz S.E. Outcome predictors for pediatric dilated cardiomyopathy: a systematic review. Prog Pediatr Cardiol 2007, 23(1-2):25-32.
32. Chung W.K. Predictive genetic testing for cardiomyopathies. Prog Pediatr Cardiol 2007, 23(1-2):33-38.
33. Kishnani P.S., Burns Wechsler S., Li J.S. Enzyme-deficiency metabolic cardiomyopathies and the role of enzyme replacement therapy. Prog Pediatr Cardiol 2007, 23(1-2):39-48.
34. Rodrigues C.O., Shehadeh L.A., Webster K.A., et al. Myocyte deficiency as a target in the treatment of cardiomyopathy. Prog Pediatr Cardiol 2007, 23(1-2):49-59.
35. Jefferies J.L. Novel medical therapies for pediatric heart failure. Prog Pediatr Cardiol 2007, 23(1-2):61-66.
36. Canter C.E., Kantor P.F. Heart transplant for pediatric cardiomyopathy. Prog Pediatr Cardiol 2007, 23(1-2):67-72.
37. Hsu D.T. Age-related factors in child heart transplants. Prog Pediatr Cardiol 2007, 23(1-2):73-79.
38. Lipshultz S.E., Colan S.D., Towbin J.A., et al. Idiopathic and primary cardiomyopathies in children. Prog Pediatr Cardiol 2007, 24(1):1.
39. Mestroni L., Miyamoto S.D., Taylor M.R.G. Genetics of dilated cardiomyopathy conduction disease. Prog Pediatr Cardiol 2007, 24(1):3-13.
40. Cox G.F. Diagnostic approaches to pediatric cardiomyopathy of metabolic genetic etiologies and their relation to therapy. Prog Pediatr Cardiol 2007, 24(1):15-25.
41. Sheikh F., Chen J. Mouse models for cardiomyopathy research. Prog Pediatr Cardiol 2007, 24(1):27-34.
42. Dellefave L.M., McNally E.M. Cardiomyopathy in neuromuscular disorders. Prog Pediatr Cardiol 2007, 24(1):35-46.
43. Cooper L.T. Giant cell myocarditis in children. Prog Pediatr Cardiol 2007, 24(1):47-49.
44. Kaufman B.D., Shaddy R.E. Beta-adrenergic receptor blockade and pediatric dilated cardiomyopathy. Prog Pediatr Cardiol 2007, 24(1):51-57.
45. Miller T.L., Neri D., Extein J., et al. Nutrition in pediatric cardiomyopathy. Prog Pediatr Cardiol 2007, 24(1):59-71.
46. Alcalai R., Arad M., Depreux F., et al. Hypertrophy, electrical abnormalities, autophagic vacuoles accumulation and cardiac fibrosis in LAMP2 cardiomyopathy mouse model. Prog Pediatr Cardiol 2007, 24(1):73-74.
47. Joshi V.A., Roberts A.E., Kucherlapati R.S. Noonan syndrome associated congenital hypertrophic cardiomyopathy and the role of sarcomere gene mutations. Prog Pediatr Cardiol 2007, 24(1):75-76.
48. Rossano J.W., Dreyer W.J., Kim J.J., et al. Pre-transplant serum creatinine predicts long-term outcome in pediatric heart transplant patients. Prog Pediatr Cardiol 2007, 24(1):77-78.
49. Taylor M.R.G. When echocardiogram screening " is not enough" Prog Pediatr Cardiol 2007, 24(1):79-80.
50. Ratnasamy C., Kinnamon D.D., Lipshultz S.E., et al. Associations between neurohormonal and inflammatory activation and heart failure in children. Prog Pediatr Cardiol 2007, 24(1):81-82.
51. Lipshultz S.E., Colan S.D., Towbin J.A., et al. Introduction for " idiopathic and primary cardiomyopathy in children" Prog Pediatr Cardiol 2008, 25(1):1.
52. Towbin J.A. Molecular mechanisms of pediatric cardiomyopathies and new targeted therapies. Prog Pediatr Cardiol 2008, 25(3):3-21.
53. Lipshultz S.E., Wilkinson J.D. Epidemiological and outcomes research in children with pediatric cardiomyopathy. Prog Pediatr Cardiol 2008, 25(3):23-25.
54. Colan S.D. Clinical issues in the pediatric hypertrophic cardiomyopathies. Prog Pediatr Cardiol 2008, 25(3):27-29.
55. Wilkinson J.D., Sleeper L.A., Alvarez J.A., et al. The Pediatric Cardiomyopathy Registry: 1995-2007. Prog Pediatr Cardiol 2008, 25(3):31-36.
56. Young K., Hare J.M. Stem cells in cardiopulmonary development: implications for novel approaches to therapy for pediatric cardiopulmonary disease. Prog Pediatr Cardiol 2008, 25(3):37-49.
57. Negro A., Dodge-Kafka K., Kapiloff M.S. Signalosomes as therapeutic targets. Prog Pediatr Cardiol 2008, 25(3):51-56.
58. Menon S.C., Olson T.M., Michels V. Genetics of familial dilated cardiomyopathy. Prog Pediatr Cardiol 2008, 25(3):57-67.
59. Hill K.D., Rizwan H., Exil V.J. Pediatric cardiomyopathies related to fatty acid metabolism. Prog Pediatr Cardiol 2008, 25(3):69-78.
60. Fisher S.D., Pearson G.D. Peripartum cardiomyopathy: an update. Prog Pediatr Cardiol 2008, 25(3):79-84.
61. Webber S.A. Primary restrictive cardiomyopathy in childhood. Prog Pediatr Cardiol 2008, 25(3):85-90.
62. Somarriba G., Extein J., Miller T.L. Exercise rehabilitation in pediatric cardiomyopathy. Prog Pediatr Cardiol 2008, 25(3):91-102.
63. Sokol K.C., Armstrong F.D., Rosenkranz E.R., et al. Ethical issues in children with cardiomyopathy: making sense of ethical challenges in the clinical setting. Prog Pediatr Cardiol 2007, 23(1-2):81-87.
64. Bublik N., Alvarez J.A., Lipshultz S.E. Pediatric cardiomyopathy as a chronic disease: a look at comprehensive care programs. Prog Pediatr Cardiol 2008, 25:103-111.
65. Dreyer N.A., Garner S. Registries for robust evidence. JAMA 2009, 302:790-791.